The article Enveric Biosciences Reports Q4 and Year-End 2022 Results was originally published on Microdose. Enveric Biosciences Reports Fourth Quarter...
The company is down to $14 million in working capital. The post Enveric Biosciences Needs More Money to Get Past 2023 appeared first on Green Market...
Tel Aviv, Israel / Vancouver, Canada, April 04, 2023 (GLOBE NEWSWIRE) — Clearmind Medicine Inc.... The post Clearmind Medicine Announces Pricing of US$3.5...
The company is down to $14 million in working capital. The post Enveric Biosciences Says It Needs More Money To Get Past 2023 appeared first on...
The article Chrisitian Angermayer Shows Faith in Atai, Buys Another 1.2 M Shares was originally published on Microdose. On March 29th, Christian Angermayer,...
The munKNEE Psychedelic Drug Stocks Index was DOWN 3.4% in March but is still UP 1.2% YTD and the average price targets of the above stocks represent...
Upon the closing which occurred on March 22, 2023, the purchase price was adjusted from... The post SciSparc completes the sale of a 49% interest in...
FSD Pharma Inc. (NASDAQ: HUGE / CSE: HUGE / FRA: 0K9A), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech...
The company spent more money on research and cut down on overhead costs. The post Atai Life Sciences Losses Shrunk in 2022 Amid Restructuring Bid appeared...
The article Lucy Scientific Acquires Psychedelic Assets from Wesana Health was originally published on Microdose. Last month, a new psychedelic firm joined...